Inhibition of NF-κB Signaling Alters Acute Myelogenous Leukemia Cell Transcriptomics

Acute myelogenous leukemia (AML) is an aggressive hematological malignancy. The pathophysiology of the disease depends on cytogenetic abnormalities, gene mutations, aberrant gene expressions, and altered epigenetic regulation. Although new pharmacological agents have emerged during the last years, t...

Descripción completa

Detalles Bibliográficos
Autor principal: Reikvam, Håkon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408594/
https://www.ncbi.nlm.nih.gov/pubmed/32664684
http://dx.doi.org/10.3390/cells9071677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408594/
https://www.ncbi.nlm.nih.gov/pubmed/32664684
http://dx.doi.org/10.3390/cells9071677

Ejemplares similares